Skip to main content
. Author manuscript; available in PMC: 2011 Mar 18.
Published in final edited form as: Cancer Biol Ther. 2008 Oct 9;7(10):1607–1618. doi: 10.4161/cbt.7.10.6584

Table 4.

Primers designed for semiquantitative PCR

Forward Reverse Size (bp)
ceacam5 5' CCT CAC TCT ACT CAG TGT CAC AAG 3' 5' CAG CCA AGA ATA CTG TGC AGG TGG 3' 220
IL1 β 5'GAT AAC GAG GCT TAT GTG CAC GAT G 3' 5' CAA CAC GCA GGA CAG GTA CAG ATT C 3' 243
cyp26A 5' GGC TGC AGC TGT TGA TCG AGC ACT C 3' 5' CAA CTT GTT GTC TTG ATT GCT CTT GC 3' 223
cyp26B 5' CCA ACA CGG TGT CCA ATT CCA TTG 3' 5' CTC GTG GCT GAA GAT CTT GGA GAA G 3' 77
txk 5' GAA CAC AGA TAA GCC TGA GCA CAG 3' 5' GAC TTG GAT CTT CTC TTC AGC AAC 3' 175
trim31 5' GAA GAA CGC AAT CAG GTT CAA CTC 3' 5' GAC TTG GAT CTG CTC TTG AAT CTG 3' 256

The forward and reverse sequences and expected product sizes are shown.